Dogwood TherapeuticsDWTX
13F holders, Q1 2025 (March 31)13holders +3
4new positions
1sold out
$5.00avg. 13F price*
At the end of Q1 2025, 13 institutions reported holding Dogwood Therapeutics Inc. (DWTX) in their 13F filings, up 3 from Q4 2024. 4 opened new positions and 1 sold out. The largest holders were UBS Group AG ($149K), Geode Capital Management, LLC ($72K) and FNY Investment Advisers, LLC ($62K).
- Company
- Dogwood Therapeutics Inc.
- CUSIP
- 92829J203
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $178K |
| Exits | 1 | $949 |
All 13F filers, Q4 2024 → Q1 2025: 51,616 shares bought and 417 shares sold, net +51,199 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 13 holders
| UBS Group AG | 0.00% | Add +68.7% | 29,818 | $149K |
| Geode Capital Management, LLC | 0.00% | Add +31.8% | 14,409 | $72K |
| FNY Investment Advisers, LLC | 0.04% | New | 12,500 | $62K |
| Vanguard Group Inc. | 0.00% | New | 11,782 | $59K |
| HRT Financial LP | 0.00% | New | 11,228 | $56K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +8.0% | 1,050 | $5K |
| Morgan Stanley | 0.00% | No change | 600 | $3K |
| FMR LLC | 0.00% | New | 225 | $1K |
| SBI Securities Co., Ltd. | 0.00% | Add +2250.0% | 188 | $942 |
| Activest Wealth Management | 0.00% | No change | 120 | $601 |
| BlackRock, Inc. | 0.00% | No change | 30 | $150 |
| Bank of America Corp. | 0.00% | No change | 10 | $50 |
| Group One Trading LLC | 0.00% | Reduce -80.0% | 9 | $45 |
"% of holder's portfolio" is DWTX's weight in each manager's 13F, not the share of Dogwood Therapeutics Inc. the manager owns.